A large nationwide study published in JAMA Network Open has found that adults who develop new-onset atrial fibrillation may experience a faster decline in kidney function compared with those who do not develop the condition. The findings are especially important because they focus on working-age adults, a group often considered relatively low risk for chronic kidney disease progression.
Atrial fibrillation (AF) is a common heart rhythm disorder where the upper chambers of the heart beat irregularly. While AF is well known for increasing stroke and heart failure risk, this research highlights another potential consequence: worsening kidney health over time.
The study also supports growing awareness of cardiovascular-kidney-metabolic (CKM) syndrome, a framework promoted by the American Heart Association that describes the interconnected decline of heart, kidney, and metabolic health.
This was a large retrospective cohort study conducted using health screening and insurance data from Japan between 2015 and 2023. It included adults aged 35 to 59 years who had normal heart rhythm at the beginning and no prior major cardiovascular or kidney disease.
Researchers identified over 23,000 individuals who developed new atrial fibrillation and compared them with more than 117,000 matched individuals who did not develop AF.
The main goal was to understand whether AF is associated with a faster yearly decline in estimated glomerular filtration rate (eGFR), a key measure of kidney function.
The study found that:
Although this difference may seem small, it becomes clinically meaningful over several years, especially in people at risk of chronic kidney disease.
Participants with atrial fibrillation were nearly three times more likely to experience a major kidney function drop:
This means AF was strongly associated with meaningful kidney deterioration, not just small changes in lab values.
The study also found that individuals whose atrial fibrillation persisted at follow-up had worse kidney outcomes than those whose heart rhythm returned to normal. This suggests that the severity or duration of AF may influence kidney damage over time.
Researchers observed that before AF developed, both groups had similar rates of kidney decline. This strengthens the idea that AF onset may contribute to later kidney deterioration rather than simply being associated with pre-existing kidney disease.
Cardiovascular-kidney-metabolic (CKM) syndrome is a relatively new medical concept introduced by the American Heart Association. It describes how heart disease, kidney disease, and metabolic disorders like diabetes are deeply connected.
Instead of treating these conditions separately, CKM syndrome encourages doctors to view them as part of one interconnected system.
This study supports that idea by showing that a heart rhythm disorder can influence kidney health in working-age adults, even in those without advanced disease at baseline.
Although this study was observational and cannot prove cause and effect, researchers discussed several possible biological explanations:
Atrial fibrillation causes irregular heartbeats, which can lead to fluctuating blood pressure and reduced steady blood flow to the kidneys.
AF may activate the renin-angiotensin-aldosterone system, a hormonal pathway that can contribute to kidney stress and damage over time.
Irregular heart function may lead to blood congestion in the kidneys, which can impair filtration efficiency.
AF increases the risk of heart failure, which itself is strongly associated with worsening kidney function through inflammation and reduced circulation.
These mechanisms suggest that AF may contribute to kidney damage through multiple overlapping pathways.
This research has several important strengths:
Like all observational studies, there are limitations to consider:
These factors mean the results should be interpreted as a strong association, not definitive proof of causation.
This study suggests that atrial fibrillation should not be viewed only as a heart rhythm problem. Instead, it may be an early warning sign of broader health risks involving the kidneys and metabolic system.
For clinicians, it highlights the importance of:
For patients, the findings emphasize the importance of:
In this large Japanese cohort study published in JAMA Network Open, new-onset atrial fibrillation was associated with a measurable acceleration in kidney function decline among working-age adults. Although the decline in eGFR was modest annually, the long-term impact could be significant, especially when combined with other risk factors such as diabetes or hypertension.
Overall, the findings reinforce the growing understanding that heart and kidney health are closely linked and should be managed together under the CKM syndrome framework. Further research is needed to determine whether treating atrial fibrillation more aggressively can slow or prevent kidney damage.
Mori Y, Hirano K, Ikenoue T, et al. New-Onset Atrial Fibrillation and Accelerated Kidney Function Decline in Working-Age Adults. JAMA Network Open. 2026;9(5):e2612823.
This article is a rewritten, SEO-optimized summary of a peer-reviewed scientific study. It is intended for informational and educational purposes only and should not be considered medical advice. The findings described are based on observational research and do not establish direct causation. Always consult a qualified healthcare professional for diagnosis, treatment, or medical guidance.
Most Accurate Healthcare AI designed for everything from admin workflows to clinical decision support.